Also note that not only is gdn the most spoken about stock today on hotcopper, but this subject is the worst subject to ever be posted on hotcopper since it's inauguration.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%